Monocyte News and Research

RSS
Study does not find association between hematological parameters and COVID-19-related hospitalization

Study does not find association between hematological parameters and COVID-19-related hospitalization

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Multigranular and visualization approach precisely predicts SARS-CoV-2 outcomes

Dual therapeutic potential of zapnometinib against COVID-19

Dual therapeutic potential of zapnometinib against COVID-19

Melatonin as a safe and potentially life-saving treatment for COVID-19

Melatonin as a safe and potentially life-saving treatment for COVID-19

Mechanisms of IL-6 expression in peripheral monocyte-derived macrophages infected with SARS-CoV-2

Mechanisms of IL-6 expression in peripheral monocyte-derived macrophages infected with SARS-CoV-2

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

Response of peripheral immune cells to ex vivo SARS-CoV-2 exposure compared to SARS-CoV

The long-term consequences of SARS-CoV-2 infection in people with HIV

The long-term consequences of SARS-CoV-2 infection in people with HIV

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

Study suggests that epigenetic memory in innate immune cells could be the key to explaining long COVID

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

Study reveals peripheral blood biomarkers able to predict COVID-19 clinical outcomes in ICU admission

Immuno-proteomic profiling suggests aberrant immune cell regulation associated with post-COVD-19 infection

Immuno-proteomic profiling suggests aberrant immune cell regulation associated with post-COVD-19 infection

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

Attenuated tissue immune responses against SARS-CoV-2 in obese and non-obese patients

Partial bone marrow transplant can dramatically improve survival of mice with cystic fibrosis

Partial bone marrow transplant can dramatically improve survival of mice with cystic fibrosis

Immune responses in Omicron breakthrough COVID-19

Immune responses in Omicron breakthrough COVID-19

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

SARS-CoV-2 interacts with heparan sulfate to activate the alternative pathway

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Study suggests myeloid cell dysregulation is a driver of COVID-19 severity

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

Study shows SARS-CoV-2 prompts NLRP3 inflammasome activation through spike-ACE2 receptor interaction

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

Similarities and dissimilarities in immune responses and metabolism in SARS-CoV-2 and HIV-1 infections

Role of leptin in immune modulation and pathophysiology of COVID-19

Role of leptin in immune modulation and pathophysiology of COVID-19

Study finds a subset of vascular macrophages to be powerful ally in the fight against atherosclerosis

Study finds a subset of vascular macrophages to be powerful ally in the fight against atherosclerosis

Unraveling the early host-immune response to SARS-CoV-2 in mild COVID-19 infections

Unraveling the early host-immune response to SARS-CoV-2 in mild COVID-19 infections

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.